New Study Shows Increased Risk of Diabetic Ketoacidosis with SGLT2 Drugs
SGLT2 Drugs Increased Risk Of Diabetic Ketoacidosis. Researchers from Brigham and Women's Hospital in Boston say a new class of type diabetes drugs is associated with an increased risk of diabetic ketoacidosis, a serious complication. In 2015, the U.S. Food and Drug Administration (FDA) issued a warning about the … [Read more...] about New Study Shows Increased Risk of Diabetic Ketoacidosis with SGLT2 Drugs
Janssen Failed To Disclose Risk Of Ketoacidosis With Invokana
Janssen Failed To Disclose Diabetic Ketoacidosis Risks. A lawsuit has been filed on behalf of a Florida woman who alleges that Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, failed to warn about the risk of ketoacidosis with its Type 2 diabetes medication, Invokana. According to court documents, the plaintiff began … [Read more...] about Janssen Failed To Disclose Risk Of Ketoacidosis With Invokana
Janssen Failed to Warn of Ketoacidosis Risk with Invokana Diabetes Drug, Suit Alleges
Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is accused of failing to warn about the risk of ketoacidosis with its type 2 diabetes drug Invokana. Diabetic ketoacidosis is a serious condition caused by the build up of ketone bodies, leading to acidic blood levels. It can result in a diabetic coma and even death. … [Read more...] about Janssen Failed to Warn of Ketoacidosis Risk with Invokana Diabetes Drug, Suit Alleges
Invokana’s Link to Ketoacidosis Allegedly Hidden by Janssen and J&J
A Florida woman alleges, in a recent lawsuit brought against the makers of Invokana--Janssen Pharmaceuticals, and its parent company Johnson & Johnson (J&J)--, that the drug makers neglected to issue a proper warning about the connection between Invokana and ketoacidosis, a condition that occurs when too much acid builds up … [Read more...] about Invokana’s Link to Ketoacidosis Allegedly Hidden by Janssen and J&J
FDA Warning: Newer Type 2 Diabetes Drugs May Cause Ketoacidosis
some of the newer Type 2 diabetes medicines may lead to ketoacidosis FDA Warns Patients About The Diabetes Drugs Ketoacidosis Risk. The Food and Drug Administration (FDA) is warning that some of the newer Type 2 diabetes medicines canagliflozin (Invokana), dapagliflozin (Farxiga), and empagliflozin (Jardiance) may lead to … [Read more...] about FDA Warning: Newer Type 2 Diabetes Drugs May Cause Ketoacidosis
FDA Warns Newer Type 2 Diabetes Drugs May Cause Ketoacidosis
The Food and Drug Administration (FDA) is warning that some of the newer Type 2 diabetes medicines—canagliflozin (Invokana), dapagliflozin (Farxiga), and empagliflozin (Jardiance)—may cause ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones. Patients with ketoacidosis may require … [Read more...] about FDA Warns Newer Type 2 Diabetes Drugs May Cause Ketoacidosis
